RNAM insider transaction filings
Avidity Biosciences, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-27. Screen RNAM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-27 | 4 | Skerjanec Simona — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 42,308 (derivative) | EDGAR |
| 2026-02-27 | 4 | McCarthy Teresa — Chief Human Resources Officer | Disposition to issuer (D): 165,296 · Disposition to issuer (D): 106,000 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 57,500 (derivative) · Disposition to issuer (D): 108,000 (derivative) · Disposition to issuer (D): 54,000 (derivative) · +2 more | EDGAR |
| 2026-02-27 | 4 | Thompson Tamar — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Hughes Steven George — Chief Medical Officer | Disposition to issuer (D): 115,857 · Disposition to issuer (D): 73,342 (derivative) · Disposition to issuer (D): 74,000 (derivative) · Disposition to issuer (D): 49,333 (derivative) · Disposition to issuer (D): 68,458 (derivative) · Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Boyce Sarah — President and CEO, Director | Disposition to issuer (D): 474,861 · Disposition to issuer (D): 386,015 (derivative) · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 425,000 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 200,000 (derivative) · +2 more | EDGAR |
| 2026-02-27 | 4 | Flanagan W. Michael — Chief Scientific Officer | Disposition to issuer (D): 150,365 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 66,500 (derivative) · Disposition to issuer (D): 96,000 (derivative) · Disposition to issuer (D): 72,000 (derivative) · Disposition to issuer (D): 88,000 (derivative) · +1 more | EDGAR |
| 2026-02-27 | 4 | Gallagher Kathleen P. — Chief Program Officer | Disposition to issuer (D): 80,303 · Disposition to issuer (D): 22,321 (derivative) · Disposition to issuer (D): 13,829 (derivative) · Disposition to issuer (D): 9,244 (derivative) · Disposition to issuer (D): 13,352 (derivative) · Disposition to issuer (D): 27,584 (derivative) · +4 more | EDGAR |
| 2026-02-27 | 4 | Henig Noreen — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +2 more | EDGAR |
| 2026-02-27 | 4 | Kim Jean Jinsun — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Mosbrooker Eric — Chief Commercial Officer | Disposition to issuer (D): 79,413 · Disposition to issuer (D): 177,188 (derivative) · Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Calderaro Charles III — Chief Technical Officer | Disposition to issuer (D): 98,547 · Disposition to issuer (D): 80,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | WILSON TROY EDWARD — Director | Disposition to issuer (D): 65,091 · Disposition to issuer (D): 13,711 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Moriarty John B — Chief Legal Officer | Disposition to issuer (D): 92,054 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 160,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Kaye Edward M. MD — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +2 more | EDGAR |
| 2026-02-27 | 4 | MacLean Michael F — Chief Financial Officer | Disposition to issuer (D): 133,977 · Disposition to issuer (D): 92,000 (derivative) · Disposition to issuer (D): 131,250 (derivative) · Disposition to issuer (D): 148,000 (derivative) · Disposition to issuer (D): 60,125 (derivative) · Disposition to issuer (D): 106,000 (derivative) · +1 more | EDGAR |
| 2026-02-27 | 4 | BOESS CARSTEN — Director | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 more | EDGAR |
| 2026-02-27 | 4 | LEVIN ARTHUR A — Director | Disposition to issuer (D): 16,562 · Disposition to issuer (D): 131,372 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 144,000 (derivative) · Disposition to issuer (D): 115,500 (derivative) · +1 more | EDGAR |
Recent 8-K events — Avidity Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-02-27 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-02-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-03 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RNAM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →